Cargando…
Clinical application of genetically modified T cells in cancer therapy
Immunotherapies are emerging as highly promising approaches for the treatment of cancer. In these approaches, a variety of materials are used to boost immunity against malignant cells. A key component of many of these approaches is functional tumor-specific T cells, but the existence and activity of...
Autores principales: | Kershaw, Michael H, Westwood, Jennifer A, Slaney, Clare Y, Darcy, Phillip K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232070/ https://www.ncbi.nlm.nih.gov/pubmed/25505964 http://dx.doi.org/10.1038/cti.2014.7 |
Ejemplares similares
-
Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities
por: Chan, Jack D., et al.
Publicado: (2020) -
Tissue-specific tumour microenvironments are an emerging determinant of immunotherapy responses
por: Oliver, Amanda J., et al.
Publicado: (2020) -
Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment
por: Kershaw, Michael H, et al.
Publicado: (2013) -
Challenges and Opportunities for Effective Cancer Immunotherapies
por: Slaney, Clare Y., et al.
Publicado: (2020) -
Environmental enrichment does not impact on tumor growth in mice
por: Westwood, Jennifer A, et al.
Publicado: (2013)